PMID- 37249463 OWN - NLM STAT- MEDLINE DCOM- 20230601 LR - 20231124 IS - 2359-4292 (Electronic) IS - 2359-3997 (Print) IS - 2359-3997 (Linking) VI - 67 IP - 5 DP - 2023 May 25 TI - Sexual dysfunction in women with type 2 diabetes mellitus: A single-centre cross-sectional study from Bangladesh. PG - e000635 LID - 2359-3997000000635 [pii] LID - 10.20945/2359-3997000000635 [doi] LID - e000635 AB - OBJECTIVE: Sexual dysfunction among women with diabetes is a common but neglected health issue worldwide. The objective of the present study was to investigate the prevalence of sexual dysfunction and its associated factors among women with type 2 diabetes mellitus (T2DM). SUBJECTS AND METHODS: This cross-sectional comparative study comprises 150 women with diabetes and 100 healthy women without diabetes who visited the endocrinology outpatient department of Mymensingh Medical College Hospital (MMCH). The data were collected from July to December 2019. Sexual dysfunction was assessed by the 19-item Female Sexual Function Index (FSFI). Informed consent was obtained before participation. Collected data were analysed by SPSS 26. RESULTS: More women with diabetes than control subjects reported sexual dysfunction (79% vs. 72%; p = 0.864). The global FSFI score was lower among the diabetes patients than among the healthy controls (20.8 +/- 7.2 vs. 23.7 +/- 4.8; p < 0.001). Patients with T2DM scored significantly lower in the domains of desire (p = 0.04), lubrication (p = 0.01), orgasm (p = 0.01), and satisfaction (p < 0.001), but not the domain of arousal (p = 0.09). A prolonged duration of diabetes was the primary contributor to orgasm problems (adjusted odds ratio, aOR 1.3, 95% CI 1.1-1.7) and painful intercourse (aOR 1.2, 95% CI 1.1- 1.5). CONCLUSION: Sexual problems are frequent in women with diabetes. Inclusion of sexual health in comprehensive diabetes management is crucial to address this problem as well as to improve the quality of life of female diabetes patients. FAU - Kamrul-Hasan, A B M AU - Kamrul-Hasan ABM AD - Department of Endocrinology, Mymensingh Medical College, Mymensingh, Bangladesh, rangassmc@gmail.com. FAU - Alam, Muhammad Shah AU - Alam MS AD - Army Medical College, Cumilla, Bangladesh. FAU - Zarin, Nusrat AU - Zarin N AD - Department of Endocrinology, Bangladesh Institute of Health Sciences, Dhaka, Bangladesh. FAU - Aalpona, Fatema Tuz Zahura AU - Aalpona FTZ AD - Outpatient Department (Gyne & Obs), Mymensingh Medical College Hospital, Mymensingh, Bangladesh. FAU - Mustari, Marufa AU - Mustari M AD - Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. FAU - Akter, Farhana AU - Akter F AD - Department of Endocrinology, Chittagong Medical College, Chittagong, Bangladesh. FAU - Jannat, Nadia AU - Jannat N AD - Department of Endocrinology, BRB Hospitals Limited, Dhaka, Bangladesh. FAU - Azad, Umme AU - Azad U AD - Department of Endocrinology, Mymensingh Medical College Hospital, Mymensingh, Bangladesh. FAU - Chanda, Palash Kumar AU - Chanda PK AD - Department of Endocrinology, Mymensingh Medical College Hospital, Mymensingh, Bangladesh. FAU - Rafi, Abdur AU - Rafi A AD - Pi Research Consultancy Center, Dhaka, Bangladesh. FAU - Hasan, Mohammad Jahid AU - Hasan MJ AD - Pi Research Consultancy Center, Dhaka, Bangladesh. FAU - Selim, Shahjada AU - Selim S AD - Department of Endocrinology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. LA - eng PT - Journal Article PL - Brazil TA - Arch Endocrinol Metab JT - Archives of endocrinology and metabolism JID - 101652058 SB - IM MH - Female MH - Humans MH - *Diabetes Mellitus, Type 2/complications/epidemiology MH - Cross-Sectional Studies MH - Quality of Life MH - Bangladesh/epidemiology MH - *Sexual Dysfunction, Physiological/epidemiology/etiology MH - Surveys and Questionnaires PMC - PMC10665051 OTO - NOTNLM OT - Bangladesh OT - FSFI OT - Prevalence OT - diabetes mellitus OT - sexual dysfunction OT - women COIS- Disclosure: no potential conflict of interest relevant to this article was reported. EDAT- 2023/05/30 13:07 MHDA- 2023/06/01 06:42 PMCR- 2023/05/29 CRDT- 2023/05/30 10:04 PHST- 2023/06/01 06:42 [medline] PHST- 2023/05/30 13:07 [pubmed] PHST- 2023/05/30 10:04 [entrez] PHST- 2023/05/29 00:00 [pmc-release] AID - 2359-3997000000635 [pii] AID - 10.20945/2359-3997000000635 [doi] PST - ppublish SO - Arch Endocrinol Metab. 2023 May 25;67(5):e000635. doi: 10.20945/2359-3997000000635.